An Alert Naming Inventory in Weeks
The American Society of Clinical Oncology has warned that some oncology practices have less than a few weeks of ifosfamide on hand, describing "critical supply disruptions" of a chemotherapy drug for which no direct substitute is available. The society published the warning through its policy news channel.